AB
Altesa BioSciences, Inc.
SEC filingPharmaceuticals · College Park, GA
Amount raised$75Msold at filing
Total offering$75M
Investors in the raise17count reported to the SEC
FiledFeb 23, 2026first sale Feb 13, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
John ClericiExecutive Officer
Nicholas WilliamsDirector
Moncef SlaouiDirector
Andrew DrechslerExecutive Officer
Seth RudnickDirector
Jon EdwardsDirector
Brett GiroirExecutive Officer, Director
Ittai HarelDirector
Executive officers, directors and promoters as listed on the Form D.